7. Degradable Dendrimers for Drug Delivery

  1. Yiyun Cheng
  1. Marc Gingras and
  2. Myriam Roy

Published Online: 14 JUN 2012

DOI: 10.1002/9781118275238.ch7

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

How to Cite

Gingras, M. and Roy, M. (2012) Degradable Dendrimers for Drug Delivery, in Dendrimer-Based Drug Delivery Systems: From Theory to Practice (ed Y. Cheng), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118275238.ch7

Editor Information

  1. School of Life Sciences, East China Normal University, P.R. China

Author Information

  1. CNRS, UMR 7325, 163 Avenue de Luminy, 13288 Marseille, France; Aix-Marseille University, CINaM, 13288 Marseille, France

Publication History

  1. Published Online: 14 JUN 2012
  2. Published Print: 15 JUN 2012

Book Series:

  1. Wiley Series in Drug Discovery and Development

Book Series Editors:

  1. Binghe Wang

ISBN Information

Print ISBN: 9780470460054

Online ISBN: 9781118275238



  • drug delivery degradable dendrimers, and dendritic scaffold;
  • dendrimers as drug scaffolds, as drug-delivery platforms and degradability;
  • dendrimer advantage over polydisperse polymers, and dispersity control;
  • biocompatibility, nonimmunogenicity, low toxicity by peripheral functionalization;
  • polytherapy, as novel anticancer and steroidal antiinflammatory drugs


This chapter contains sections titled:

  • Introduction

  • Dendrimer-Drug Conjugates as Prodrugs

  • Anticancer Dendrimer-Drug Conjugates

  • Anticancer Multifunctional Dendritic Platforms with Targeting Units

  • Anticancer Dendritic Platforms for Polytherapy

  • Antiinflamatory Dendrimer-Drug Conjugates

  • Antibacterial and Antimicrobial Dendrimer-Drug Conjugates

  • Concluding Remarks

  • Acknowledgments

  • References